| Trial Identifier: | D9603R00022 |
| Sponsor: | AstraZeneca |
| Start Date: | July 2024 |
| Primary Completion Date: | November 2024 |
| Study Completion Date: | November 2024 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| AE | Abu Dhabi, AE |
| AE | Al Ain, AE |
| Argentina | Buenos Aires, Argentina |
| Brazil | Joinville, Brazil |
| Brazil, Brazil | Porto Alegre, Brazil, Brazil |
| Colombia | Bogota, Colombia |
| Mexico | Ciudad de Mexico, Mexico |
| Qatar | Doha, Qatar |
| SA | Mekkah, SA |
| SA | Riyadh, SA |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company